503 related articles for article (PubMed ID: 14970020)
1. Glial tumor grading and outcome prediction using dynamic spin-echo MR susceptibility mapping compared with conventional contrast-enhanced MR: confounding effect of elevated rCBV of oligodendrogliomas [corrected].
Lev MH; Ozsunar Y; Henson JW; Rasheed AA; Barest GD; Harsh GR; Fitzek MM; Chiocca EA; Rabinov JD; Csavoy AN; Rosen BR; Hochberg FH; Schaefer PW; Gonzalez RG
AJNR Am J Neuroradiol; 2004 Feb; 25(2):214-21. PubMed ID: 14970020
[TBL] [Abstract][Full Text] [Related]
2. Cerebral blood volume measurements by perfusion-weighted MR imaging in gliomas: ready for prime time in predicting short-term outcome and recurrent disease?
Bisdas S; Kirkpatrick M; Giglio P; Welsh C; Spampinato MV; Rumboldt Z
AJNR Am J Neuroradiol; 2009 Apr; 30(4):681-8. PubMed ID: 19179427
[TBL] [Abstract][Full Text] [Related]
3. Comparing perfusion metrics obtained from a single compartment versus pharmacokinetic modeling methods using dynamic susceptibility contrast-enhanced perfusion MR imaging with glioma grade.
Law M; Young R; Babb J; Rad M; Sasaki T; Zagzag D; Johnson G
AJNR Am J Neuroradiol; 2006 Oct; 27(9):1975-82. PubMed ID: 17032878
[TBL] [Abstract][Full Text] [Related]
4. Perfusion magnetic resonance imaging predicts patient outcome as an adjunct to histopathology: a second reference standard in the surgical and nonsurgical treatment of low-grade gliomas.
Law M; Oh S; Johnson G; Babb JS; Zagzag D; Golfinos J; Kelly PJ
Neurosurgery; 2006 Jun; 58(6):1099-107; discussion 1099-107. PubMed ID: 16723889
[TBL] [Abstract][Full Text] [Related]
5. Perfusion-sensitive MR imaging of gliomas: comparison between gradient-echo and spin-echo echo-planar imaging techniques.
Sugahara T; Korogi Y; Kochi M; Ushio Y; Takahashi M
AJNR Am J Neuroradiol; 2001 Aug; 22(7):1306-15. PubMed ID: 11498419
[TBL] [Abstract][Full Text] [Related]
6. Multimodal MRI in the characterization of glial neoplasms: the combined role of single-voxel MR spectroscopy, diffusion imaging and echo-planar perfusion imaging.
Zonari P; Baraldi P; Crisi G
Neuroradiology; 2007 Oct; 49(10):795-803. PubMed ID: 17619871
[TBL] [Abstract][Full Text] [Related]
7. Correlation between cerebral blood volume measurements by perfusion-weighted magnetic resonance imaging and two-year progression-free survival in gliomas.
Spampinato MV; Schiarelli C; Cianfoni A; Giglio P; Welsh CT; Bisdas S; Rumboldt Z
Neuroradiol J; 2013 Aug; 26(4):385-95. PubMed ID: 24007727
[TBL] [Abstract][Full Text] [Related]
8. Gliomas: application of cumulative histogram analysis of normalized cerebral blood volume on 3 T MRI to tumor grading.
Kim H; Choi SH; Kim JH; Ryoo I; Kim SC; Yeom JA; Shin H; Jung SC; Lee AL; Yun TJ; Park CK; Sohn CH; Park SH
PLoS One; 2013; 8(5):e63462. PubMed ID: 23704910
[TBL] [Abstract][Full Text] [Related]
9. Differentiation of cerebral tumors using multi-section echo planar MR perfusion imaging.
Preul C; Kühn B; Lang EW; Mehdorn HM; Heller M; Link J
Eur J Radiol; 2003 Dec; 48(3):244-51. PubMed ID: 14652141
[TBL] [Abstract][Full Text] [Related]
10. Characterization of a first-pass gradient-echo spin-echo method to predict brain tumor grade and angiogenesis.
Schmainda KM; Rand SD; Joseph AM; Lund R; Ward BD; Pathak AP; Ulmer JL; Badruddoja MA; Krouwer HG
AJNR Am J Neuroradiol; 2004 Oct; 25(9):1524-32. PubMed ID: 15502131
[TBL] [Abstract][Full Text] [Related]
11. Dynamic Contrast-Enhanced MRI in Low-Grade Versus Anaplastic Oligodendrogliomas.
Arevalo-Perez J; Kebede AA; Peck KK; Diamond E; Holodny AI; Rosenblum M; Rubel J; Gaal J; Hatzoglou V
J Neuroimaging; 2016 May; 26(3):366-71. PubMed ID: 26707628
[TBL] [Abstract][Full Text] [Related]
12. Dynamic susceptibility contrast and diffusion MR imaging identify oligodendroglioma as defined by the 2016 WHO classification for brain tumors: histogram analysis approach.
Latysheva A; Emblem KE; Brandal P; Vik-Mo EO; Pahnke J; Røysland K; Hald JK; Server A
Neuroradiology; 2019 May; 61(5):545-555. PubMed ID: 30712139
[TBL] [Abstract][Full Text] [Related]
13. Histogram analysis of MR imaging-derived cerebral blood volume maps: combined glioma grading and identification of low-grade oligodendroglial subtypes.
Emblem KE; Scheie D; Due-Tonnessen P; Nedregaard B; Nome T; Hald JK; Beiske K; Meling TR; Bjornerud A
AJNR Am J Neuroradiol; 2008 Oct; 29(9):1664-70. PubMed ID: 18583405
[TBL] [Abstract][Full Text] [Related]
14. Correlation between progression free survival and dynamic susceptibility contrast MRI perfusion in WHO grade III glioma subtypes.
Mangla R; Ginat DT; Kamalian S; Milano MT; Korones DN; Walter KA; Ekholm S
J Neurooncol; 2014 Jan; 116(2):325-31. PubMed ID: 24178441
[TBL] [Abstract][Full Text] [Related]
15. Role of perfusion-weighted imaging at 3 Tesla in the assessment of malignancy of cerebral gliomas.
Di Costanzo A; Pollice S; Trojsi F; Giannatempo GM; Popolizio T; Canalis L; Armillotta M; Maggialetti A; Carriero A; Tedeschi G; Scarabino T
Radiol Med; 2008 Feb; 113(1):134-43. PubMed ID: 18338133
[TBL] [Abstract][Full Text] [Related]
16. Paradoxical perfusion metrics of high-grade gliomas with an oligodendroglioma component: quantitative analysis of dynamic susceptibility contrast perfusion MR imaging.
Sunwoo L; Choi SH; Yoo RE; Kang KM; Yun TJ; Kim TM; Lee SH; Park CK; Kim JH; Park SW; Sohn CH; Won JK; Park SH; Kim IH
Neuroradiology; 2015 Nov; 57(11):1111-20. PubMed ID: 26232204
[TBL] [Abstract][Full Text] [Related]
17. Low-grade gliomas: dynamic susceptibility-weighted contrast-enhanced perfusion MR imaging--prediction of patient clinical response.
Law M; Oh S; Babb JS; Wang E; Inglese M; Zagzag D; Knopp EA; Johnson G
Radiology; 2006 Feb; 238(2):658-67. PubMed ID: 16396838
[TBL] [Abstract][Full Text] [Related]
18. High-grade and low-grade gliomas: differentiation by using perfusion MR imaging.
Hakyemez B; Erdogan C; Ercan I; Ergin N; Uysal S; Atahan S
Clin Radiol; 2005 Apr; 60(4):493-502. PubMed ID: 15767107
[TBL] [Abstract][Full Text] [Related]
19. Magnetic resonance perfusion for differentiating low-grade from high-grade gliomas at first presentation.
Abrigo JM; Fountain DM; Provenzale JM; Law EK; Kwong JS; Hart MG; Tam WWS
Cochrane Database Syst Rev; 2018 Jan; 1(1):CD011551. PubMed ID: 29357120
[TBL] [Abstract][Full Text] [Related]
20. Differentiation of low-grade oligodendrogliomas from low-grade astrocytomas by using quantitative blood-volume measurements derived from dynamic susceptibility contrast-enhanced MR imaging.
Cha S; Tihan T; Crawford F; Fischbein NJ; Chang S; Bollen A; Nelson SJ; Prados M; Berger MS; Dillon WP
AJNR Am J Neuroradiol; 2005 Feb; 26(2):266-73. PubMed ID: 15709123
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]